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Abstract 
Objective: The objective of this research was to gather physicians’ perception of pharmacists providing chronic disease management 
and identify trends in physicians’ characteristics that could potentially impact their comfort level collaborating with pharmacists. 
Method: Physicians practicing in the outpatient setting in the state of Washington were invited to participate in a voluntary, 
anonymous survey. Physicians practicing in a large multidisciplinary outpatient clinic in the Southwest Washington and Seattle areas 
were included. For Likert scale questions, median values were reported. Physicians’ characteristics were also correlated with their 
willingness to collaborate with pharmacists in the provision of clinical services.    
Results: Results were analyzed using descriptive statistics to summarize the data collected to determine which pharmacist provided 
clinical services physicians would like to collaborate on. Physicians were most comfortable with pharmacists reviewing patients’ 
medications followed by pharmacist provision of disease state education and least comfortable with pharmacists initiating therapy. 
Physicians that have worked with pharmacists in the past were more likely to collaborate with pharmacists compared to physicians 
that have never worked with a pharmacist. Furthermore, pharmacists’ ability to bill patients’ medical insurance did not influence 
physicians’ likelihood to collaborate with pharmacists.  
Conclusion: This information will be used to aid in the determination of future directions for the implementation of additional clinical 
services within the community pharmacy setting.  Additionally, it is anticipated that pharmacists will be able to utilize this 
information to initiate conversations with physicians in an effort to collaborate on new pharmacist provided clinical services as well 
as improve patient outcomes by increasing access to healthcare providers, including pharmacists. 
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Introduction 
According to the Association of American Medical Colleges 
(AAMC), there is a significant physician shortage in the United 
States. AAMC estimates that by 2025 there will be a shortage of 
35,600 primary care physicians (PCPs). It takes roughly ten 
years to train physicians and the number of medical students 
choosing primary care is slowly declining1. These shortage 
numbers may be a low estimate given not everyone seeks care 
when needed or follows up appropriately with their PCPs. This 
shortage may potentially have a significant impact on patient 
outcomes by creating a gap in patients attaining timely and 
quality healthcare. Despite this documented shortage and a 
lack of clear plan to resolve the shortage, community 
pharmacists are underutilized in alleviating this healthcare 
burden. Community pharmacists have a significant opportunity 
to improve patient outcomes by playing a larger role in 
providing chronic disease state management2. Not only are 
community pharmacists one of the most accessible healthcare 
providers, they are cost effective as well3. Several large health 
systems and government entities have historically utilized 
pharmacists in the management of a variety of disease states. 
Physician-pharmacist collaboration has the potential to reduce  
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gaps in care that are predicted because of the physician 
shortage. Furthermore, studies have shown that inclusion of a 
pharmacist on a healthcare team results in significant 
improvement in patient outcomes5. Community pharmacists 
are in a prime position to provide cost effective, convenient, 
and quality healthcare, however collaboration with physicians 
plays a key role in the success of implementing this innovative 
approach.  
 
Objectives  
The objective of this research was to gather physicians’ 
perception of pharmacists providing chronic disease 
management, identify trends in physicians’ characteristics that 
could potentially impact their comfort level collaborating with 
pharmacists, and evaluate whether legislation allowing 
pharmacists to bill commercial medical insurance influences 
physicians’ likelihood to collaborate with pharmacists.     
 
Methods  
A peer-reviewed survey was distributed to physicians in person 
or via email. Survey questions included Likert scale, multiple 
choice, and open text, which were analyzed using descriptive 
analysis.  
 
A list of the top one hundred prescribers was generated by a 
retail pharmacy chain at thirteen of their locations in 
Vancouver, Olympia, and Seattle, Washington (WA) areas. The 
list of prescribers was filtered to only include physician 
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prescribers. Ten physicians were randomly selected from each 
pharmacy location and their office was contacted to participate 
in this voluntary and anonymous survey. Upon agreement to 
participate in the study a Qualtrics link was sent via email to the 
physician’s office. Additionally, researchers partnered with an 
outpatient multi-specialty physician owned clinic in Vancouver, 
WA. At this location, paper copies of the survey were 
distributed to all physicians during a monthly all provider 
meeting. Completion of the survey was anonymous and 
voluntary. Those completed were collected at the conclusion of 
the meeting. All physicians practicing in the outpatient setting 
regardless of their specialty were included in this study. The 
duration of the study was December 2017 through February 
2018. This study was reviewed and considered to be exempt by 
the Washington State University Institutional Review Board. 
 
Results 
Responses were received from 71 physicians. The majority of 
physicians in the survey (n=51) were from Vancouver, WA while 
the remainder (n=20) were based out of Seattle, WA and 
surrounding areas. Of all the respondents, 14 physicians were 
from family medicine, 6 physicians were from internal 
medicine, while the other 51 physicians were specialists. Most 
physicians agreed or strongly agreed (n=53) that they felt 
comfortable with pharmacists providing chronic disease 
management, while 7 were neutral, and 11 disagreed/strongly 
disagreed. The most desired pharmacist provided clinical 
services were reviewing patients’ medications (n=60), provision 
of chronic disease state management (n=54), and refill 
authorizations (n=50), while the least desired clinical service 
was pharmacist initiation of therapy (n=19) (See Table 1).  In 
addition, data was analyzed to identify physician characteristics 
of those more likely to collaborate with pharmacists. Of those 
physicians comfortable or very comfortable with pharmacists 
providing follow up care for their patients (n=30), 26 had 
worked with a pharmacists at least once before. Physicians’ 
length of experience practicing medicine may also impact their 
perception of pharmacists. Physicians that graduated more 
recently were more likely to feel comfortable and collaborate 
with pharmacists in comparison to physicians practicing 
medicine for a longer period of time (See Table 2). Pharmacists’ 
ability to bill medical insurance did not impact physicians’ 
comfort level with pharmacists providing patient care. The 
majority of physicians were either neutral (n=31) or 
disagreed/strongly disagreed (n=17) when asked if they were 
more likely to collaborate with a pharmacist due to the ability 
to bill a patient’s medical insurance.    
 
Discussion 
Most physicians agreed or strongly agreed that they would 
collaborate with pharmacists to provide chronic disease 
management. The data also indicated that physicians practicing 
for a shorter period of time felt more comfortable collaborating 
with pharmacists. More and more schools have started to 
incorporate inter-professional training, which allows each 
healthcare professional to recognize how other healthcare 
professionals play a vital part in providing care for the patient. 
This is further highlighted by the fact that a large majority of 
physicians would like pharmacists to provide disease state 
education to the patients. The survey results show the 
perception of pharmacists is evolving. Furthermore, the results 
show that familiarity with a pharmacist may also play a key role 
in physicians’ comfort level with pharmacists providing chronic 
disease state management. As the traditional pharmacy 
practice of solely dispensing and counseling on medications is 
dissipating and reimbursement for prescriptions is decreasing, 
pharmacists are playing a larger role in providing 
comprehensive healthcare. In order to expand services offered, 
pharmacists will need to continue to develop relationships and 
use a collaborative approach to increase patient access to 
quick, convenient, and quality healthcare. Hurdles do exist that 
are preventing widespread adoption of pharmacist provided 
chronic disease management. Two hurdles are the financial 
viability of pharmacist-provided services and access to 
technology that allows the pharmacist to document patient 
encounters that satisfies Centers of Medicare & Medicaid 
Services (CMS) standards and communicate efficiently with 
other healthcare providers. The results of this study show 
pharmacists’ ability to bill medical insurance did not impact 
physicians’ willingness or unwillingness to collaborate with 
pharmacists. It is important to note that all physicians in this 
study were employed by large organizations. Executives of 
those organizations or physicians practicing privately, whom 
are more likely to be financially impacted, may have a different 
opinion. This could provide another stream of revenue for the 
organization and they may be more likely to add pharmacists 
for quality and cost effective care. The current technology, or 
the lack of, also presents many challenges. The technology 
barrier that currently exists limits communication between 
pharmacists and other healthcare providers thus hindering 
comprehensive care for patients in multiple ways.  Pharmacists 
providing immunizations and other chronic disease 
management services may lead to fragmented care given there 
is hardly any shared software that allows for two-way electronic 
communications between physicians and community 
pharmacies. Community pharmacies often send faxes to 
physicians’ offices notifying them of services provided, 
however, faxes are unreliable and the chances of that 
information being included in the patient chart is low. As 
several national and state pharmacy associations are looking 
for a solution to these hurdles, it is imperative that pharmacists 
and physicians form a symbiotic relationship in order to adapt 
to challenges posed by this evolving healthcare system.   
 
Limitations 
There were several limitations in this study. The sample size 
was small and results may not be applicable to the general 
physician population. Surveys were collected via two different 
methods. In-person survey collection by a pharmacist 
researcher may have introduced bias by introducing the topic 
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rather than having participants read about the study on their 
own. All physicians from Vancouver, WA in this study are 
employed by a single outpatient clinic. The outpatient clinic has 
an established relationship with a community pharmacy chain 
and the familiarity may introduce a bias in their responses.        
 
Conclusion 
Overall, physician perception of pharmacists providing chronic 
disease management was positive. As the role of pharmacists 
continues to expand, identifying physician partners will be key 
to the pharmacy profession increasing access to chronic disease 
management. These partnerships could lead to additional 
collaborative practice agreements with pharmacists, as well as 
support for legislation expanding access to pharmacist-
provided care. Furthermore, as legislation requiring health 
plans recognize pharmacists as providers continues to gain 
momentum at a national level, the pharmacy profession will 
benefit from established clinical services and inter-professional 
collaboration to improve patient outcomes and reduce gaps in 
healthcare.      
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Table 1: Physicians’ responses as to which clinical services they would like pharmacists to offer (n=71) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 2: Physicians that feel "Comfortable" or “Very Comfortable" having a pharmacist provide chronic disease management 
 
 
 
 
 
 
 
 
 
Clinical Services Physicians would like Pharmacists to Perform
Review All 
Medications 
n (%)
Disease State 
Education 
n (%)
Refill 
Authorization 
n (%)
Therapy 
Modification 
n (%)
Follow-Up 
Care 
n (%)
Therapy Initiation
n (%)
YES 60 (85) 54 (76) 50 (70) 41 (58) 29 (41) 19 (27)
NO 11 (15) 17 (24) 21 (30) 30 (42) 42 (59) 52 (73)
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